bi 764198
Small moleculeexperimental
Clinical trial activity
10 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Mar 15, 2019 (NCT03854552)
Timeline
Indications
Mechanism of action
TRPC6 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07308652 | Phase 1 | Feb 9, 2026 | Boehringer Ingelheim |
| NCT07220083 | Phase 3 | Dec 5, 2025 | Boehringer Ingelheim |
| NCT06955754 | Phase 1 | May 20, 2025 | Boehringer Ingelheim |
| NCT05213624 | Phase 2 | Mar 10, 2022 | Boehringer Ingelheim |
| NCT04665700 | Phase 1 | Jan 22, 2021 | Boehringer Ingelheim |
| NCT04656288 | Phase 1 | Jan 15, 2021 | Boehringer Ingelheim |
| NCT04604184 | Phase 2 | Nov 3, 2020 | Boehringer Ingelheim |
| NCT04176536 | Phase 1 | Dec 10, 2019 | Boehringer Ingelheim |
| NCT04102462 | Phase 1 | Oct 28, 2019 | Boehringer Ingelheim |
| NCT03854552 | Phase 1 | Mar 15, 2019 | Boehringer Ingelheim |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 10 | 10 | 3 | 2019 |
1 organizations
Page 1 / 1